Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine vs Dexamethasone as Adjuvants in Bier Block
NCT03021772Phase 3
Key facts
- Status
- Completed
- Start
- Jan 2017
- Primary completion
- Sep 2018
- Countries
- 1
- Sponsor
- Assiut University
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of neostigmine and dexamethasone, sponsored by Assiut University. Primary endpoint: Visual Analogue Scale at 24 hours. Started Jan 2017; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Endpoints
Primary
Visual Analogue Scale
Beyond the preview
Go deeper on NCT03021772.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03021772.